Incannex Healthcare Limited Common Stock

IXHLNASDAQ • USD
2.85 USD
↗ 0.03 (0.89%)🟢PRE MARKET (AS OF 07:28 AM EDT)
🟢Market: OPEN

IXHL is currently priced at $2.85. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Oct 16, 2026.

Open?$2.85
High?$2.85
Low?$2.85
Prev. Close?$2.82
Volume?1.9K
Avg. Volume?N/A
VWAP?$2.85
Bid / Ask
Bid?$2.38 × 100
Ask?$3.31 × 100
Spread?$0.93
Midpoint?$2.84
Valuation & Ratios
Market Cap?35.4M
Shares Out?N/A
Float?11.8M
Float %?98.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
Employees
12
Market Cap
35.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-02-25
Address
8 CENTURY CIRCUIT
NORWEST NSW,
Phone: 61 409 840 786
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?3.85%Low
Short Interest?456.1K
Days to Cover?3.9
Free Float11.8M
Avg Daily Volume117.5K
Settlement Date2026-09-30